06:46 AM EDT, 04/18/2024 (MT Newswires) -- Michael J. LaBarre, SVP, CHIEF TECHNICAL OFFICER, around April 16, 2024, sold 20,000 shares in Halozyme Therapeutics ( HALO ) for $768,390. Following the Form 4 filing with the SEC, LaBarre has control over a total of 168,176 shares of the company, with 168,176 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1159036/000141588924011058/xslF345X03/form4-04172024_110437.xml